Page last updated: 2024-10-31

neostigmine and Mydriasis

neostigmine has been researched along with Mydriasis in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Mydriasis: Dilation of pupils to greater than 6 mm combined with failure of the pupils to constrict when stimulated with light. This condition may occur due to injury of the pupillary fibers in the oculomotor nerve, in acute angle-closure glaucoma, and in ADIE SYNDROME.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tabboush, ZS1

Other Studies

1 other study available for neostigmine and Mydriasis

ArticleYear
Accidental prolonged mydriasis in anesthesiologists.
    Anesthesia and analgesia, 1995, Volume: 81, Issue:6

    Topics: Accidents, Occupational; Adjuvants, Anesthesia; Anesthesiology; Atropine; Cholinesterase Inhibitors;

1995